Oct. 28 (Bloomberg) -- Bavarian Nordic A/S said it has received a performance-based milestone payment of $25 million under the contract with the U.S. government to deliver 20 million doses of its smallpox vaccine, IMVAMUNE.

Link to Statement:{NSN LTRI233V2802 <GO>}

To contact the editor responsible for this story: Christian Wienberg at cwienberg@bloomberg.net